How many has Novo poached from us?

Quote
Anonymous said:
You are right. Novo reps are the best sales people that have ever existed. I mean, look how well they have done with Levemir vs Lantus.
Click to expand...

Do you mean getting 20% of the basal insulin market with a clearly inferior product? Not too bad if you ask me. Look at what S-A has done with Apidra--it's at least as good as Humalog & Novolog, been out a year longer than Levemir, and they still have less than 4% of the short-acting insulin market. Thanks for pointing out a place where NNI has shown had good they really are. Seems like you would have learned your lesson--Byetta market share disappeared once Novo launched a GLP-1, and Bydureon hasn't done anything, even with a HUGE advantage in dosing. Compete against NNI, and you lose.
 




Anonymous said:
Do you mean getting 20% of the basal insulin market with a clearly inferior product? Not too bad if you ask me. Look at what S-A has done with Apidra--it's at least as good as Humalog & Novolog, been out a year longer than Levemir, and they still have less than 4% of the short-acting insulin market. Thanks for pointing out a place where NNI has shown had good they really are. Seems like you would have learned your lesson--Byetta market share disappeared once Novo launched a GLP-1, and Bydureon hasn't done anything, even with a HUGE advantage in dosing. Compete against NNI, and you lose.
Click to expand...

You are right, Novo clearly awesome. To get 20% with an admittantly inferior product. Very Good. So if you know Levemir is inferior, how do you sell it? Paying off "speakers"? BJ's every Friday? Begging docs to "help you out" because your manager is on your ass?

Don't get me wrong-I respect your transparency. Then only difference between us and hookers is that hookers drive better cars.
 




Coming from a manager....really...it's called selling dumbass. We have all had to sell less than superior products in our day .....but if we are good we do the job. Hellooooo it's called sales....
 




Anonymous said:
You are right, Novo clearly awesome. To get 20% with an admittantly inferior product. Very Good. So if you know Levemir is inferior, how do you sell it? Paying off "speakers"? BJ's every Friday? Begging docs to "help you out" because your manager is on your ass?

Don't get me wrong-I respect your transparency. Then only difference between us and hookers is that hookers drive better cars.
Click to expand...

We SELL. Try it sometime. It will do wonders for you.
 




Anonymous said:
Agree.

It is all about reach and frequency metrics. A sales rep is a sales rep is a sales rep. When the goal is too keep throwing shit against the wall to see what sticks-what matters is how many pieces of shit you have to throw vs making sure you have a good fat sticky piece.
Click to expand...

That was worth checking into CP--LOL! Thanks--
 




Anonymous said:
Do you mean getting 20% of the basal insulin market with a clearly inferior product? Not too bad if you ask me. Look at what S-A has done with Apidra--it's at least as good as Humalog & Novolog, been out a year longer than Levemir, and they still have less than 4% of the short-acting insulin market. Thanks for pointing out a place where NNI has shown had good they really are. Seems like you would have learned your lesson--Byetta market share disappeared once Novo launched a GLP-1, and Bydureon hasn't done anything, even with a HUGE advantage in dosing. Compete against NNI, and you lose.
Click to expand...

Wow. Time for honoring yourself will soon come to an end.
 








Top Bottom
Back
Quote